Order results by:
| Issue | Title | |
| Vol 16, No 1 (2020) | The Efficacy, Safety and Adherence to Treatment when New Anticoagulants Taking in Over 75 Years Old Patients with Atrial Fibrillation | Abstract similar documents |
| A. N. Turov, S. V. Panfilov, О. V. Tschiglinzeva | ||
| "... of myocardial infarction was 0.8% per year, surgical revascularization – 0.9% per year, cardiovascular death – 0 ..." | ||
| Vol 10, No 6 (2014) | THE ASSESSMENT OF COMPLIANCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE PROFILE REGISTER | Abstract similar documents |
| S. Y. Martsevich, A. R. Navasardyan, N. P. Kutishenko, A. V. Zakharova, V. P. Voronina, N. A. Dmitrieva, L. Yu. Lrozdova, A. V. Zagrebelnyy, O. V. Lerman, Yu. V. Lukina, G. V. Martynova, A. A. Nikulina, G. S. Ryazanova, A. Yu. Suvorov, S. N. Tolpygina | ||
| "... Aim. To study in the PROFILE register the rate of new oral anticoagulants (NOAC) taking ..." | ||
| Vol 11, No 5 (2015) | Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism | Abstract similar documents |
| A. V. Rudakova | ||
| "... horizon of the study was 5 years. Life expectancy and costs were discounted by 3.5% per year. The costs ..." | ||
| Vol 15, No 6 (2019) | Adherence to Treatment with New Oral Anticoagulants in Atrial Fibrillation Patients in Real Clinical Practice (Results of the ANTEY Study) | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, N. A. Komkova | ||
| "... Aim. To study adherence to treatment with new oral anticoagulants (NOAC) and factors associated ..." | ||
| Vol 13, No 5 (2017) | DRUG INTERACTIONS OF NEW ORAL ANTICOAGULANTS: INSIDE AND OUTSIDE TABLE CELLS | Abstract similar documents |
| S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov | ||
| "... favorable profile of drug interaction in comparison with other new oral anticoagulants (NOAC). The basis ..." | ||
| Vol 13, No 5 (2017) | Drug interactions of non-vitamin K antagonist oral anticoagulants: inside and outside table cells | Abstract similar documents |
| Sergey Nikolaevich Bel'diev, Irina Vladimirovna Medvedeva, Dmitry Jur'evich Platonov | ||
| "... profile of drug interaction in comparison to other non-vitamin K antagonist oral anticoagulants (NOAC ..." | ||
| Vol 14, No 4 (2018) | Risk Controlling of Gastrointestinal Bleeding in Comorbid Patients with Cardiovascular Diseases | Abstract similar documents |
| O. Yu. Chizhova, L. N. Belousova, I. G. Bakulin | ||
| "... anticoagulants (NOACs), previously known as new oral anticoagulants are used in the treatment and prevention ..." | ||
| Vol 14, No 2 (2018) | WHAT DO PATIENTS WITH ATRIAL FIBRILLATION KNOW ABOUT STROKE AND SYSTEMIC EMBOLISM PREVENTION? DATA OF THE PRIMA-TERRA REGISTRY | Abstract similar documents |
| R. М. Linchak, O. G. Kompaniyets, A. M. Nedbaykin | ||
| "... . The ratio of men and women was 42% vs 58%, respectively, the average age was 65.6Ѓ}8.2 years. The AF ..." | ||
| Vol 12, No 4 (2016) | The use of oral anticoagulants in patients with atrial fibrillation: cohort study data | Abstract similar documents |
| O. V. Gaisenok, A. S. Leonov | ||
| "... OAC (NOAC), prescription depending type AF and the reasons for their not-prescribing were studied ..." | ||
| Vol 16, No 1 (2020) | Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice | Abstract similar documents |
| A. A. Zarudsky, A. A. Gavrilova, Т. S. Filinichenko | ||
| "... of 62.55±11.12 years. Exclusion criteria were mitral stenosis, mechanic prosthetic valve, first episode ..." | ||
| Vol 12, No 4 (2016) | Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true | Abstract similar documents |
| Yu. A. Bunin, S. V. Miklishanskaya | ||
| "... . In connection with the known disadvantages of warfarin use, the elaboration of new oral anticoagulants (NOAC ..." | ||
| Vol 12, No 6 (2016) | Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis | Abstract PDF (Eng) similar documents |
| V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov | ||
| "... Aim. Analysis of the efficacy and safety of the new oral anticoagulants (NOACs) in the management ..." | ||
| Vol 12, No 1 (2016) | Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis | Abstract similar documents |
| V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov | ||
| "... Aim. Analysis of the efficacy and safety of the new oral anticoagulants (NOACs) in the management ..." | ||
| Vol 12, No 5 (2016) | Treatment Adherence as a New Choice Factor for Optimization of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation and Hemostatic Gene Polymorphisms | Abstract PDF (Eng) similar documents |
| Yu. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolayev | ||
| "... . Material and methods. Treatment adherence was evaluated in 137 AF patients (aged 35-85 years ..." | ||
| Vol 14, No 4 (2018) | Hepatotoxicity of New Oral Anticoagulants | Abstract similar documents |
| A. R. Kasimova, A. V. Philippova (Guryanova), A. S. Kolbin | ||
| "... of various manifestations of liver damage in the use of the new oral anticoagulants (NOAC) for the registered ..." | ||
| Vol 12, No 3 (2016) | THE ADVANCED TACTICS OF THE MANAGEMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM: THE ROLE OF RIVAROXABAN AT VARIOUS STAGES OF TREATMENT | Abstract PDF (Eng) similar documents |
| S. R. Gilyarevskiy | ||
| "... , as well as the choice of anticoagulants, including new oral anticoagulants (NOAC). EINSTEIN-PE is the only ..." | ||
| Vol 12, No 5 (2016) | Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation | Abstract similar documents |
| N. A. Novikova, A. N. Volovchenko | ||
| "... lately new oral anticoagulants (NOAC) are becoming more common for the prevention of thromboembolic ..." | ||
| Vol 13, No 5 (2017) | WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT | Abstract similar documents |
| S. Yu. Martsevich, Y. V. Lukina | ||
| "... of new OAC (NOAC) also appeared. In Russia, dabigatran, rivaroxaban and apixaban have been registered ..." | ||
| Vol 10, No 6 (2014) | THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY | Abstract similar documents |
| A. A. Rumyantsev, I. A. Pokataev, T. V. Kozlov, N. A. Rumyantsev | ||
| "... problems. New oral anticoagulants (NOAC) are promising drugs for use in oncology practice; however ..." | ||
| Vol 15, No 4 (2019) | The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) | Abstract similar documents |
| M. M. Loukianov, S. Yu. Martsevich, O. M. Drapkina, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. Y. Andreenko, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, M. A. Panagopulu, S. A. Boytsov | ||
| "... .7 years, 43.1% men. The incidence of OAC administration was evaluated in hospital and outpatient settings ..." | ||
| Vol 14, No 3 (2018) | APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova | ||
| "... oral anticoagulants (NOAC) instead of vitamin K antagonists (eg, warfarin), low doses of NOAC, studied ..." | ||
| Vol 14, No 5 (2018) | Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin | ||
| "... This article affects the problems of using NOAC in the most defenseless groups of patients ..." | ||
| Vol 6, No 4 (2010) | GUIDELINES FOR PRE-OPERATIVE CARDIAC RISK ASSESSMENT AND PERIOPERATIVE CARDIAC MANAGEMENT IN NON-CARDIAC SURGERY | Abstract similar documents |
| Don Poldermans, Jeroen J. Bax, Eric Boersma, Stefan De Hert, Erik Eeckhout, Gerry Fowkes, Bulent Gorenek, Michael G. Hennerici, Bernard Iung, Malte Kelm, Keld Per Kjeldsen, Steen Dalby Kristensen, Jose Lopez-Sendon, Paolo Pelosi, François Philippe, Luc Pierard, Piotr Ponikowski, Jean-Paul Schmid, Olav F.M. Sellevold, Rosa Sicari, Greet Van den Berghe, Frank Vermassen, M. O. Evseev | ||
| "... (Германия); Per Anton Sirnes (Норвегия); Michal Tendera (Польша); Panos Vardas (Греция); Petr Widimsky ..." | ||
| Vol 6, No 3 (2010) | GUIDELINES FOR PRE-OPERATIVE CARDIAC RISK ASSESSMENT AND PERIOPERATIVE CARDIAC MANAGEMENT IN NON-CARDIAC SURGERY | Abstract similar documents |
| Don Poldermans, Jeroen J. Bax, Eric Boersma, Stefan De Hert, Erik Eeckhout, Gerry Fowkes, Bulent Gorenek, Michael G. Hennerici, Bernard Iung, Malte Kelm, Keld Per Kjeldsen, Steen Dalby Kristensen, Jose Lopez-Sendon, Paolo Pelosi, François Philippe, Luc Pierard, Piotr Ponikowski, Jean-Paul Schmid, Olav F.M. Sellevold, Rosa Sicari, Greet Van den Berghe, Frank Vermassen, M. O. Evseev | ||
| "... (Германия); Per Anton Sirnes (Норвегия); Michal Tendera (Польша); Panos Vardas (Греция); Petr Widimsky ..." | ||
| Vol 10, No 2 (2014) | PRIMARY PREVENTION OF MYOCARDIAL INFARCTION IN MIDDLE-AGED MALES (15-YEAR FOLLOW-UP): CLINICAL AND ECONOMIC ASPECTS OF THE PROBLEM | Abstract PDF (Eng) similar documents |
| A. M. Kalinina, A. V. Kontsevaya | ||
| "... -aged men during 15-year follow-up; to evaluate economic efficiency of primary medical prevention ..." | ||
| Vol 15, No 2 (2019) | Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology | Abstract similar documents |
| S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov, G. Yu. Trufanova | ||
| "... oral anticoagulants (NOAC): 1) none of the randomized controlled trials (RCTs) with NOAC (except ..." | ||
| Vol 15, No 2 (2019) | Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology | Abstract similar documents |
| Sergey N. Bel'diev, Irina V. Medvedeva, Dmitry Yu. Platonov, Galina Yu. Trufanova | ||
| "... rivaroxaban among other non-vitamin K antagonist oral anticoagulants (NOAC): 1) none of the randomized ..." | ||
| Vol 11, No 3 (2015) | EVALUATION OF THE REGULARITY OF ANTIHYPERTENSIVE DRUGS USAGE AS A COMPONENT OF TREATMENT ADHERENCE IN OUTPATIENTS OF A SPECIALIZED CARDIOLOGY CENTER | Abstract PDF (Eng) similar documents |
| A. V. Kontsevaya, T. S. Romanenko, V. A. Vygodin, S.B B. Fitilev | ||
| "... .8), those without coronary heart disease (OR=1.9), with hypertension duration less than 5 years (OR=1 ..." | ||
| Vol 9, No 3 (2013) | ECONOMIC EVALUATION OF COMBINED THERAPY OF ARTERIAL HYPERTENSION BY MARKOV’S MODELING | Abstract similar documents |
| N. S. Maksimchuk-Kolobova, E. I. Tarlovskaya, S. V. Malchikova | ||
| "... 1000 patients. It would reduce the total costs per patient during 10 years. V/A therapy is able to save ..." | ||
| Vol 9, No 4 (2013) | NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY | Abstract similar documents |
| A. V. Rudenko, B. A. Rudenko | ||
| "... поколений. Его высокая антигипертензивная активность не вызывает сомнения. Но при выборе амлодипина для ..." | ||
| Vol 20, No 4 (2024) | Comparison of the quality of logistic regression models and a classification tree in predicting hospital mortality in elderly patients with non-ST-elevation myocardial infarction | Abstract similar documents |
| K. G. Pereverzeva, S. S. Yakushin, N. N. Peregudova, M. V. Mishutina | ||
| "... (non-STEMI) aged 75 years and older and compare the quality of the constructed model with the logistic ..." | ||
| Vol 15, No 6 (2019) | Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation | Abstract similar documents |
| M. A. Gabitova, P. M. Krupenin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin | ||
| "... Aim. To study the safety of non-vitamin K oral anticoagulants (NOAC) in patients with atrial ..." | ||
| Vol 19, No 6 (2023) | Refusal of prescribed drug therapy (absolute non-adherence) after acute myocardial infarction/unstable angina: data from prospective observation in the LIS-3 registry | Abstract similar documents |
| S. Yu. Martsevich, N. P. Zolotareva, A. V. Zagrebelnyy, N. P. Kutishenko, Yu. V. Lukina, M. L. Ginzburg, O. M. Drapkina | ||
| "... of absolutely nonadherent patients, disease outcomes after 2.5 years after first contact. Material and methods ..." | ||
| Vol 3, No 2 (2007) | CARDIAC RUPTURE IN MYOCARDIAL INFARCTION: INCIDENCE AND PREDISPOSING FACTORS (15 YEAR FOLLOW-UP) | Abstract similar documents |
| V. A. Shulman, S. E. Golovenkin, V. V. Radionov, T. M. Parfenova, G. V. Matyushin | ||
| "... infarction (MI) as well as predisposing factors during 15-year follow-up. Material and methods. 1453 ..." | ||
| Vol 17, No 2 (2021) | Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage | Abstract similar documents |
| A. S. Gerasimenko, V. S. Gorbatenko, O. V. Shatalova, V. I. Petrov | ||
| "... with an incidence 0.3-0.7% per year. For patients with atrial fibrillation (AF) anticoagulants are administered ..." | ||
| Vol 11, No 5 (2015) | Excess winter cardiovascular morbidity in Ivanovo Region in 2009-2013 years | Abstract similar documents |
| A. V. Kontsevaya, J. A. Balanova, M. M. Loukianov, M. B. Khudyakov, O. A. Belova, S. V. Romanchuk | ||
| "... a year. Aim. To study excess cardiovascular morbidity during winter in Ivanovo Region in 2009-2013 years ..." | ||
| Vol 13, No 3 (2017) | ARTERIAL STIFFNESS AND CARDIOVASCULAR RISK FACTORS IN YOUNG MEN (41-44 YEARS) | Abstract PDF (Eng) similar documents |
| O. Yu. Isaykina, V. B. Rozanov, E. Yu. Zvolinskaya, H. S. Pugoeva, A. A. Alexandrov | ||
| "... and subclinical atherosclerosis in young men. Material and methods. The study is part of a 32-year prospective ..." | ||
| Vol 17, No 2 (2021) | Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation in Real Clinical Practice: in Appropriate Dose Reductions | Abstract similar documents |
| V. A. Ionin, O. I. Bliznuk, E. I. Baranova, E. V. Shlyakhto | ||
| "... ) patients. Material and methods. 10663 case histories of patients hospitalized for 5 years (2014-2018) were ..." | ||
| Vol 14, No 3 (2018) | HEART RATE LEVELS IN THE POPULATIONS OF THE RUSSIAN FEDERATION AND THE UNITED STATES OF AMERICA DURING THE THIRTY-YEAR PERSPECTIVE | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, V. G. Vilkov, A. V. Kapustina, A. D. Deev | ||
| "... number of cases was 48974. Results. In 80th years of XX century Russian men and women of all age groups ..." | ||
| Vol 11, No 4 (2015) | EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME | Abstract similar documents |
| A. V. Rudakova, N. V. Lomakin | ||
| "... rates for St. Petersburg in 2014. The cost and life expectancy were discounted at 3.5% per year ..." | ||
| Vol 15, No 3 (2019) | The Prevalence of Smoking in 41-43-Year-Old Males and its Relation to Some Risk Factors | Abstract PDF (Eng) similar documents |
| A. A. Alexandrov, M. V. Kotova, E. I. Ivanova, V. B. Rozanov | ||
| "... Aim. To evaluate the prevalence of smoking in 41-43-year-old men living in Moscow and its ..." | ||
| Vol 11, No 3 (2015) | PHARMACOECONOMIC ASPECTS OF THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER LARGE JOINTS REPLACEMENT | Abstract similar documents |
| A. V. Rudakova | ||
| "... . The costs and life expectancy of patients were discounted at 3.5% per year. Results. The best results ..." | ||
| Vol 2, No 1 (2006) | PROPAFENONE FOR SINUS RHYTHM RECOVERY AND SUPPORT IN PATIENTS WITH PERSISTENT FORM OF AURICULAR FIBLILLATION. “PROMETHEUS” – OPENED MULTICENTER STUDY IN RUSSIAN FEDERATION | Abstract similar documents |
| I. G. Fomina, A. I. Tarzimanova, A. V. Vetluzsky, , , , , , , , , , , , , , , , , | ||
| "... . 503 patients with the persistent form of AF, aged 31-68 years were included into multicenter study ..." | ||
| Vol 18, No 1 (2022) | Three Year Prognosis of Patients with Myocardial Infarction Depending on the Body Weight Index: Data of the Kemerovo Acute Coronary Syndrome Registry | Abstract PDF (Eng) similar documents |
| D. Yu. Sedykh, A. I. German, O. N. Hryachkova, V. V. Kashtalap, O. L. Barbarash | ||
| "... Aim. To study the effect of body mass index (BMI) on the 3-year prognosis of patients after ..." | ||
| Vol 13, No 5 (2017) | IRON DEFICIENCY AND ANEMIA IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| N. I. Stuklov | ||
| "... В статье рассматриваются проблемы дефицита железа и анемии при хронической сердечной ..." | ||
| Vol 11, No 2 (2015) | THE INFLUENCE OF INSULIN RESISTANCE ON THE FORMATION AND PROGRESSION OF METABOLIC SYNDROME COMPONENTS (THE RESULTS OF A FIVE-YEAR STUDY) | Abstract similar documents |
| G. E. Roytberg, J. V. Dorosh, O. O. Sharkhun | ||
| "... syndrome components on the basis of a 5-year follow-up. Material and methods. An outpatient examination ..." | ||
| Vol 20, No 4 (2024) | The evolution of evidence-based methods of acute myocardial infarction treatment: is there any reason for optimism in recent years? | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... действующих на сегодняшний момент КР позволило существенно снизить госпитальную летальность при остром ИМ и ..." | ||
| Vol 10, No 1 (2014) | MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) | Abstract PDF (Eng) similar documents |
| A. M. Kalinina | ||
| "... Aim. To evaluate in a prospective 10-year follow-up study cardiovascular mortality rate ..." | ||
| Vol 14, No 2 (2018) | FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova | ||
| "... Aim. To assess five-year trend in terms of specialists’ adherence to guidelines on secondary ..." | ||
| Vol 16, No 5 (2020) | Treatment of Patients with Acute Coronary Syndrome with ST Segment Elevation in Clinical Practice of the Republic of Karelia: the Results of 10-year Register | Abstract similar documents |
| I. S. Skopets, N. N. Vezikova, A. V. Malafeev, A. N. Malygin, V. A. Litvinova | ||
| "... (65.8%); the average age was 68 years old. 14.1% of the patients had the history of myocardial ..." | ||
| Vol 15, No 5 (2019) | Comparative Study of the Results of a Three-year Observation of Cardiologists and Surgeons in Patients with Peripheral Atherosclerosis | Abstract similar documents |
| L. S. Barbarash, A. N. Sumin, Yu. D. Medvedeva, E. V. Korok | ||
| "... Aim. To compare the results of 3-year follow-up of patients with peripheral atherosclerosis (PA ..." | ||
| Vol 7, No 5 (2011) | THE ADHERENCE TO RECOMMENDED THERAPY IN PATIENTS AFTER ACUTE CORONARY SYNDROME, AND RISK OF CARDIOVASCULAR COMPLICATIONS WITHIN A YEAR AFTER HOSPITAL ADMISSION | Abstract similar documents |
| N. F. Puchin'yan, Ya. P. Dovgalevskiy, P. V. Dolotovskaya, N. V. Furman | ||
| "... to recommended therapy on the risk of cardiovascular events during a year after hospital admission ..." | ||
| Vol 14, No 6 (2018) | Evaluation of Drug Therapy and Adherence to It in Patients after Acute Coronary Syndrome in Real Clinical Practice (Results of One Year Observation) | Abstract PDF (Eng) similar documents |
| L. A. Khaisheva, S. E. Glova, V. A. Suroedov, A. S. Samakaev, S. V. Shlyk | ||
| "... coronary syndrome (ACS) in real clinical practice within a year after the index event. Material and methods ..." | ||
| Vol 20, No 6 (2024) | Dehydroepiandrosterone and cognitive impairment and impact in cardiovascular mortality among men and women 55 years and older | Abstract similar documents |
| S. A. Shalnova, N. A. Imaeva, A. E. Imaeva, V. A. Kutsenko, Yu. A. Balanova, A. V. Kapustina, O. M. Drapkina | ||
| "... and cognitive impairment and their impact in cardiovascular mortality among the population 55 years and older ..." | ||
| Vol 3, No 5 (2007) | RENAL HEMODYNAMICS AND GLOMERULAR FILTRATION RATE IN MEN AND WOMEN WITH ARTERIAL HYPERTENSION AT THE AGE OF 40-60 YEARS | Abstract similar documents |
| I. G. Fomina, A. E. Bragina, N. E. Gaydamakina, J. N. Salimzhanova | ||
| "... отрицательная связь средней силы между ОСКФ и индексом массы тела (ИМТ) (r=-0,41; p<0,005). Заключение. При ГБ ..." | ||
| Vol 6, No 3 (2010) | ASSOCIATION OF CLINICAL AND GENETIC FACTORS WITH LEFT VENTRICLE HYPERTROPHY IN ARTERIAL HYPERTENSION | Abstract PDF (Eng) similar documents |
| T. Yu. Kuznetsova, D. V. Gavrilov, L. M. Samohodskaya, D. V. Rebrikov, S. A. Morozova, P. I. Makarevich, A. V. Kolotvin, A. B. Balatsky, A. Yu. Postnov, S. A. Boitsov | ||
| "... included 184 healthy persons. Genotyping with single-nucleotide substitutions of the endothelial ..." | ||
| Vol 20, No 5 (2024) | Effectiveness and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis of clinical trials | Abstract similar documents |
| E. M. Mezhonov, Z. M. Safiullina, Y. A. Vyalkina, S. V. Shalaev | ||
| "... oral anticoagulants" or "direct oral anticoagulants" or "novel oral anticoagulant" or "emNOAC/em" or "DOAC ..." | ||
| Vol 17, No 6 (2021) | Factors Determining the Three-Year Dynamics of Lipid Metabolism Indicators in Residents of a Large Industrial Region of Siberia | Abstract similar documents |
| D. P. Tsygankova, E. D. Bazdyrev, E. V. Indukaeva, A. S. Agienko, O. V. Nakhratova, G. V. Artamonova, O. L. Barbarash | ||
| "... . Material and methods. Clinical and epidemiological prospective study of the population 35-70 emyears/em old ..." | ||
| Vol 7, No 2 (2011) | LIPRIMAR®. FIFTEEN YEARS OF EVIDENCE | Abstract similar documents |
| A. V. Susekov, N. V. Khokhlova | ||
| Vol 8, No 2 (2012) | COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| O. P. Bobrova, M. M. Petrova | ||
| "... . Patients (n=40) 75–90 emyears/em with HT were included in the open randomized comparative study. Patients were ..." | ||
| Vol 20, No 6 (2024) | Medical treatment of cardiovascular diseases in patients after hospitalization for COVID-19 (three-year follow-up data in the TARGET-VIP registry) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, M. M. Loukianov, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, E. Yu. Okshina, A. A. Smirnov, A. G. Soplenkova, A. A. Pulin, N. N. Kuzina, D. A. Nefedova, V. G. Klyashtorniy, O. E. Karpov, O. M. Drapkina | ||
| "... of medicines upon discharge from the hospital was 60%, after 3 emyears/em this indicator decreased to 41.4% (p0 ..." | ||
| Vol 18, No 5 (2022) | Assessment and Correction of the Cardiac Complications Risk in Non-cardiac Operations – What's New? | Abstract similar documents |
| A. N. Sumin | ||
| "... . The need for surgical interventions is approximately 5,000 procedures emper/em 100,000 population, according ..." | ||
| Vol 16, No 5 (2020) | Associations of Blood Pressure and Heart Rate and Their Contribution to the Development of Cardiovascular Complications and All-Cause Mortality in the Russian Population of 25-64 Years | Abstract similar documents |
| S. A. Shalnova, V. A. Kutsenko, A. V. Kapustina, E. B. Yarovaya, Yu. A. Balanova, S. E. Evstifeeva, A. E. Imaeva, S. A. Maksimov, G. A. Muromtseva, N. V. Kulakova, O. N. Kalachikova, T. M. Chernykh, O. A. Belova, G. V. Artamonova, E. V. Indukaeva, Yu. I. Grinshtein, R. A. Libis, D. V. Duplyakov, O. P. Rotar, I. A. Trubacheva, V. N. Serebryakova, A. Yu. Efanov, A. O. Konradi, S. A. Boytsov, O. M. Drapkina | ||
| "... and women 25-64 emyears/em old and their predictive value for the development of fatal and non-fatal ..." | ||
| Vol 7, No 3 (2011) | EFFECT OF THERAPEUTIC TRAINING AND ACTIVE OUTPATIENT MANAGEMENT ON CLINICAL STATE AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE (THREE YEAR FOLLOW-UP) | Abstract similar documents |
| A. P. Rebrov, N. A. Kosheleva | ||
| "... (CHF) during three emyear/em follow-up. Material and methods. A total of 211 patients with CHF experienced ..." | ||
| Vol 19, No 5 (2023) | Patients with atrial fibrillation in outpatient practice: clinical characteristics and outcomes over a 10-year observation period (data from the REQUAZA AF registrу — Yaroslavl) | Abstract similar documents |
| V. V. Yakusevich, V. Vl. Yakusevich, S. Yu. Martsevich, M. M. Lukyanov, O. M. Drapkina | ||
| "... cardiovascular events) in outpatients with atrial fibrillation (AF) in one of the Yaroslavl clinics for 10 emyears/em ..." | ||
| Vol 13, No 6 (2017) | ASSESSMENT OF CHANGES IN QUALITY OF PREHOSPITAL TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME IN THE LAST FEW YEARS: LIS-1 VS LIS-3 REGISTRIES | Abstract similar documents |
| Yu. V. Semenova, A. V. Zagrebelnyy, N. P. Kutishenko, M. L. Ginzburg, S. Yu. Martsevich | ||
| "... during the last emyears/em on the basis of the LIS-3 registry data. Material and methods. Data of acute ..." | ||
| Vol 12, No 1 (2016) | Leonid B. Lazebnik is 75 years | Abstract similar documents |
| Editorial article | ||
| Vol 13, No 1 (2017) | SERGEY A. BOYTSOV IS 60 YEARS OLD | Abstract similar documents |
| статья Редкционная | ||
| Vol 6, No 5 (2010) | 5 YEARS WITH RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | Abstract similar documents |
| "... 5 emyears/em with Rational Pharmacotherapy in Cardiology. ..." | ||
| Vol 9, No 6 (2013) | FEATURES OF SEASONAL CARDIOVASCULAR MORTALITY IN WINTER IN RUSSIAN REGIONS WITH DIFFERENT CLIMATIC AND GEOGRAPHICAL CHARACTERISTICS | Abstract similar documents |
| S. A. Boytsov, M. M. Lukyanov, A. V. Kontsevaya, A. D. Deev, Yu. A. Balanova, A. V. Kapustina, V. G. Klyashtorny, M. B. Hudyakov | ||
| "... .9% emper/em emyear/em and emper/em January-March, December, respectively (p0.0001). Higher cardiovascular mortality ..." | ||
| Vol 19, No 3 (2023) | Ventricular tachycardia and myocardial infarction during antiarrhythmic therapy: a case report | Abstract similar documents |
| A. A. Gurbanova, K. G. Pereverzeva, S. S. Yakushin, I. V. Budanova | ||
| "... infarction (MI) in an 80-emyear/em-old patient with a history of coronary artery disease, MI and chronic heart ..." | ||
| Vol 16, No 2 (2020) | LIS-3 Acute Coronary Syndrome Registry: Changes in Clinical and Demographic Characteristics and Tactics of Prehospital and Hospital Treatment of Surviving Patients After Acute Coronary Syndrome Over a 4-Year Period | Abstract similar documents |
| S. Yu. Martsevich, A. V. Zagrebelnyy, N. P. Zolotareva, N. P. Kutishenko, Yu. V. Lukina, M. L. Ginzburg, D. A. Startsev, S. V. Blagodatskikh | ||
| "... the cardiology department over a 4-emyear/em period in patients after acute coronary syndrome (ACS) with ST segment ..." | ||
| Vol 16, No 3 (2020) | The Main Cardiovascular Complications and Mortality Rates During the First One and a Half Years after Acute Myocardial Infarction: Data from the Prospective Outpatient Registry PROFILE-IM | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, D. P. Sichinava, E. P. Kalaydzhyan, E. A. Kasparova, A. V. Zagrebelnyy, Yu. V. Lukina, V. A. Evdakov | ||
| "... was 1.5 emyears/em. The primary combined endpoint (PCE) included death from any cause, cardiovascular events ..." | ||
| Vol 8, No 1 (2012) | PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
| Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov | ||
| "... events, summarized as events emper/em 100 patient-emyears/em, expected life emyears/em, total costs, and incremental ..." | ||
| Vol 12, No 6 (2016) | VLADIMIR S. ZADIONCHENKO IS 75 YEARS OLD! | Abstract similar documents |
| . editorial | ||
| Vol 5, No 3 (2009) | ACADEMICIAN E.I. CHAZOV – 80 YEARS OLD | Abstract similar documents |
| "... Academician E.I. Chazov – 80 emyears/em old. ..." | ||
| Vol 5, No 5 (2009) | ACADEMICIAN E.I. SOKOLOV – 80 YEARS OLD | Abstract similar documents |
| "... Academician E.I. Sokolov – 80 emyears/em old. ..." | ||
| Vol 13, No 5 (2017) | ANATOLY I. MARTYNOV IS 80 YEARS OLD! | Abstract similar documents |
| статья Редакционная | ||
| Vol 13, No 6 (2017) | Pavel Ya. Dovgalevsky is 70 years old! | Abstract similar documents |
| article editotial | ||
| Vol 14, No 1 (2018) | ACADEMICIAN YURY N. BELENKOV IS 70 YEARS OLD | Abstract similar documents |
| article editorial | ||
| Vol 14, No 5 (2018) | Professor Ildus A. Latfullin is 80 years old | Abstract similar documents |
| article Editorial | ||
| Vol 20, No 6 (2024) | Blood pressure variability — 15 years later | Abstract similar documents |
| V. M. Gorbunov, E. V. Platonova | ||
| "... of scientists in recent emyears/em. In a recent study in patients who participated in the ASCOT-BPLA cohort (mean ..." | ||
| Vol 12, No 2 (2016) | LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY) | Abstract similar documents |
| N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, A. N. Tkacheva, A. S. Lishuta | ||
| "... cardiovascular risk patients in real outpatient practice. Material and methods. Patients ≥30 emyears/em, visited ..." | ||
| Vol 12, No 6 (2016) | THE PROGNOSIS IN TRANSCATHETER AORTIC VALVE IMPLANTATION | Abstract similar documents |
| T. E. Imaev, A. E. Komlev, R. S. Akchurin | ||
| "... replacement, immediately after surgery, before the expiry of 30 days. Mean follow-up was 2.2 emyears/em (range 0 ..." | ||
| Vol 7, No 5 (2011) | ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| Yu. B. Belousov, I. S. Yavelov, D. Yu. Belousov, E. V. Afanasieva | ||
| "... and international normalized ratio (INR) control for patients with atrial fibrillation (AF) emper/em 1 emyear/em of treatment ..." | ||
| Vol 15, No 4 (2019) | Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova | ||
| "... of major bleeding was 1.7 emper/em 100 patient-emyears/em, and gastrointestinal bleeding was 0.7 emper/em 100 patient ..." | ||
| Vol 10, No 3 (2014) | COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION | Abstract similar documents |
| A. V. Rudakova, V. A. Parfenov | ||
| "... and life-emyears/em) were discounted at 3.5%. Cost-effectiveness threshold was set at 1.4 million rubles emper/em ..." | ||
| Vol 5, No 3 (2009) | REPERFUSION THERAPY IN ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION | Abstract similar documents |
| A. L. Alyavi, B. A. Alyavi | ||
| "... (first group). 25 patients of the second group had STL with Streptokinase, i/v, 1 500 000 units emper/em hour ..." | ||
| Vol 17, No 4 (2021) | Obstructive sleep apnea and cardiovascular comorbidity: common pathophysiological mechanisms to cardiovascular disease | Abstract similar documents |
| M. V. Agaltsov, O. M. Drapkina | ||
| "... . Хотя в обзоре эти реакции рассматриваются раздельно, emпри/em развитии апноэ во сне они происходят ..." | ||
| Vol 16, No 6 (2020) | Healthy Diet: New Rations for Individual Use | Abstract similar documents |
| O. B. Shvabskaia, N. S. Karamnova, O. V. Izmailova | ||
| Vol 7, No 5 (2011) | ECONOMIC BENEFITS OF LEFT VENTRICULAR HYPERTROPHY REGRESSION IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchicova, M. V. Avksentieva, I. E. Sapozhnikova, Y. A. Balandina | ||
| "... 516 772.42 RUR for every 1 000 patients. It would reduce the total costs emper/em patient during 10 emyears/em ..." | ||
| Vol 15, No 6 (2019) | Association of Family History of Cardiovascular Diseases in Boys Aged 12-13 Years with Structural and Functional Indicators of the Left Ventricle and Arterial Stiffness in the Age of 43-46 Years (Results of 32-Year Prospective Follow-up) | Abstract similar documents |
| O. Yu. Isaykina, V. B. Rozanov, A. A. Aleksandrov, I. V. Leontyeva, M. B. Kotova, E. I. Ivanova | ||
| "... aged 12-13 emyears/em with the development of structural and functional changes in the left ventricle ..." | ||
| Vol 7, No 1 (2011) | THE CHOICE OF THE DRUG AMLODIPINE FOR THE HYPERTENSION TREATMENT FROM THE STANDPOINT OF ECONOMIC FEASIBILITY | Abstract similar documents |
| S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, Yu. V. Lukina, L. A. Sokolova, V. V. Yakusevich | ||
| "... . In case of insufficient antihypertensive effect dose of amlodipine was increased to 10 mg emper/em day ..." | ||
| Vol 17, No 1 (2021) | Asymptomatic Supraventricular Arrhythmias in Patients Undergoing Dialysis | Abstract similar documents |
| O. V. Likhachev-Mishchenko, A. A. Kornienko, N. A. Kornienko, L. A. Khaisheva, A. A. Dyuzhikov, S. V. Shlyk | ||
| "... (hazard ratio [HR] 1.04 emper/em emyear/em; 95% confidence interval [CI] 1.00-1.08) and an increase of the atrium ..." | ||
| Vol 11, No 3 (2015) | RENAL DENERVATION IN THE TREATMENT OF RESISTANT HYPERTENSION: RESULTS OF A ONE-YEAR OBSERVATIONAL STUDY | Abstract similar documents |
| V. A. Sulimov, A. V. Rodionov, A. A. Svetankova | ||
| Vol 11, No 5 (2015) | Three-year dynamics and unsolved problems of lipid-lowering therapy | Abstract similar documents |
| V. A. Sergeeva | ||
| "... in 3 emyears/em. Material and methods. Patients with dyslipidemia (113 patients in 2011 and 100 patients ..." | ||
| Vol 7, No 1 (2011) | RESULTS OF TENEKTEPLASE USE IN MASSIVE PULMONARY THROMBOEMBOLISM. CLINICAL CASE | Abstract similar documents |
| R. Rajan, R. Natarajan, G. Vijayaraghavan | ||
| "... in the literature. Clinical case of the tenekteplase use in 42 emyears/em old woman with acute massive PTE and its ..." | ||
| Vol 14, No 3 (2018) | RELATION OF DISTURBANCES IN THE ERYTHROCYTES ELECTRICAL ACTIVITY WITH DYSLIPIDEMIA IN THE METABOLIC SYNDROME | Abstract similar documents |
| V. I. Podzolkov, T. V. Koroleva, A. E. Bragina, M. G. Kudryavtseva, G. I. Bragina, M. V. Pisarev | ||
| "... ). Material and methods. 112 patients (mean age 61.4±7.2 emyears/em) with MS (average duration of MS 8.7±5.2 emyears/em ..." | ||
| Vol 14, No 2 (2018) | PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS | Abstract similar documents |
| S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov | ||
| "... of efficacy and safety data. Time horizon was set at 3 emyears/em. Quality Adjusted Life emYears/em (QALY) were used ..." | ||
| Vol 13, No 1 (2017) | CLINICAL AND ECONOMICAL COMPARISON OF RIVAROXABAN AND APIXABAN USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
| S. V. Nedogoda, I. N. Barykina, A. S. Salasiuk, V. O. Smirnova | ||
| "... 49558.43 rubles for one patient emper/em emyear/em. The strategy of apixaban application costs higher by 0 ..." | ||
| 1 - 100 of 1423 Items | 1 2 3 4 5 6 7 8 9 10 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
.jpg)
